Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-42847922 crossover study in adults with insomnia disorder
NL-OMON42553Phase 2Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of seltorexant in Insomnia (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Latency to persistent sleep, Total sleep time and 5 more. Started Aug 2015; status: active, not recruiting.
02
Drugs
seltorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON42553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42553.